Improving Anticoagulation Therapy Services
Tuesday 29 November 2016
Hallam Conference Centre, London
Follow the conference on twitter #Anticoagulation
This conference will focus on the important issue of improving anticoagulation therapy services: patient safety and quality.
The conference will open with latest evidence for safe anticoagulation practice, and patient self monitoring and empowering patients following recommendation from NICE on self monitoring which stated that “The evidence shows that greater use of self-monitoring offers clinical and patient benefit and, over time, is likely to result in reductions in heart attacks and strokes caused by blood clots…People on long-term anticoagulation need to monitor their blood regularly to make sure they are taking the right dose of their drug. Because self monitoring provides almost instant results, self-monitoring can reduce anxiety, provide a sense of control for the patient and remove the need to frequently attend clinics or hospitals..” Professor Carole Longson, NICE Health Technology Evaluation Centre Director
The conference will continue with an update on monitoring adherence to the revised AF guidelines and Quality Standard. NICE has recommended that anticoagulants should be offered instead of aspirin for stroke prevention. Implementing CG180 may result in approximately 10,000 fewer strokes per year in people with AF, however Anticoagulation Europe state that “Over half a million people in the UK with atrial fibrillation are either not being given anticoagulant therapy to reduce their risk of stroke or are taking aspirin”.
Afternoon sessions will focus on improving safety in anticoagulation practice and reducing medication errors, complex anticoagulation issues such as Anticoagulation in the frail, restarting anticoagulation after a bleed, oral anticoagulants combined with anti-platelet drugs, the management of new oral anticoagulants, case study analysis and an in depth session developing your skills in root cause analysis of an anticoagulation incident.
100% of the delegates at our last anticoagulation therapy conference would recommend this conference.